The IHC findings of this study indicate that the increase in CD44 expression is not in parallel with the histopathological types of WHO in NPC, as one WHO type I sample had moderate positive expression (++), and two samples had strong positive expression (+++). This evidence concerns the gene CD44 and nasopharyngeal carcinoma.